2020’s Market Was More Complex Than It Will Appear
MarketFoolery
The Motley Fool
4.7 • 1.7K Ratings
🗓️ 30 December 2020
⏱️ 15 minutes
🧾️ Download transcript
Summary
AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | It's Wednesday, December 30th. |
| 0:04.0 | Welcome to Market Fullry. |
| 0:05.0 | I'm Chris Hill with me today. |
| 0:07.0 | Mr. Bill Barker. |
| 0:08.0 | Happy, almost end of 2020. |
| 0:12.0 | Thank you and to you as well. almost end of 2020. |
| 0:15.0 | Thank you and to you as well. How's how's the end of 2020 going for you? |
| 0:18.0 | You'll tune in tomorrow. |
| 0:20.0 | Turn in tomorrow. |
| 0:22.0 | We're actually going to spend a couple of minutes looking back on what an unusual |
| 0:28.4 | year it's been for the market and we're also going to look ahead to 2021 because I want to get your thoughts on a couple of |
| 0:35.0 | predictions that I'm seeing out there in the financial media but we should start with |
| 0:41.4 | the news of the day which is that Britain becomes the first country |
| 0:45.1 | to approve AstraZeneca's vaccine for COVID-19. |
| 0:49.6 | Here in the US, the FDA still has to review large-scale trials but this is this is good news for |
| 0:57.7 | the people in Britain although you wouldn't know it from the movement of |
| 1:02.0 | AstraZeneca's stock because it's basically flat today. |
| 1:05.6 | Yeah and flat for the year. Of course at this point the marginal, you know, you know, news on a third vaccine isn't what it was for either of the first two, |
| 1:20.0 | although at the end of the day this may be the most important one in terms of vaccinating people |
| 1:26.7 | because it doesn't have the same cold storage requirements that the Pfizer and Moderna vaccines have, it can be distributed throughout parts of the world |
| 1:38.0 | that really aren't going to be able to work with those vaccines. |
| 1:42.0 | And it's also because it's AstraZeneca, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.